NAMPT and cancer: A recent study identified a positive feedback loop consisting of MYC, the nicotinamide-phosphoribosyltransferase (NAMPT) enzyme, the SIRT1 inhibitor deleted in breast cancer 1 (DBC1) and SIRT1 [63].